<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for cardiac surgery: General principles</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for cardiac surgery: General principles</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for cardiac surgery: General principles</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Atilio Barbeito, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric A JohnBull, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3017405944"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Anesthetic management for different types of cardiac surgical procedures such as coronary artery bypass grafting (CABG), cardiac valve repair or replacement, surgery involving the ascending aorta, heart transplantation, and procedures for surgical repair of congenital heart defects has many shared principles. This topic will discuss general principles for anesthetic management of adults undergoing cardiac surgery with cardiopulmonary bypass (CPB). Similar techniques are employed for patients undergoing cardiac surgery without the aid of CPB (eg, off-pump CABG).</p><p>Anesthetic management issues for specific types of cardiac surgical procedures are discussed in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery"</a> and  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Off-pump coronary artery bypass surgery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/114430.html" rel="external">"Anesthesia for heart transplantation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/114421.html" rel="external">"Anesthesia for surgical repair of congenital heart defects in adults: General management"</a> and  <a class="medical medical_review" href="/z/d/html/122847.html" rel="external">"Anesthesia for surgical repair of congenital heart defects in adults: Management of specific lesions and reoperation"</a>.)</p><p></p><p>For cardiac surgical procedures requiring CPB, key steps are noted in the table  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>), and intraoperative management during and after CPB is discussed in individual topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/90614.html" rel="external">"Weaning from cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass"</a>.)</p><p></p><p>Multidisciplinary approaches including standardized preoperative, intraoperative and postoperative care protocols to enhance recovery after cardiac surgery (ERACS) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)"</a>.)</p><p class="headingAnchor" id="H1186177776"><span class="h1">PREANESTHETIC CONSULTATION</span><span class="headingEndMark"> — </span>Preanesthetic consultation involves assessing cardiac and overall health risks to identify issues that could cause problems during and after cardiac surgery. The anesthesiologist works with the cardiologist and cardiac surgeon to optimize medical conditions, develops an anesthetic care plan, educates the patient and family regarding anesthetic care, and alleviates patient anxiety. These issues are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/94291.html" rel="external">"Preoperative evaluation for anesthesia for cardiac surgery"</a>.)</p><p class="headingAnchor" id="H2091957683"><span class="h1">PREMEDICATION</span><span class="headingEndMark"> — </span>Some cardiac surgical patients benefit from premedication with small incremental doses of a short-acting intravenous (IV) benzodiazepine anxiolytic (eg, <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 1 to 2 mg) and/or opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 50 mcg), administered under the anesthesiologist's observation, particularly during placement of intravascular catheters (see <a class="local">'Intravascular cardiac monitors'</a> below). Extra caution (ie, careful titration of smaller doses) is warranted for many cardiac surgical patients. Examples include those with critical aortic stenosis or severe ventricular dysfunction, or those of extreme age (&gt;80 years old).</p><p>Protocols for enhanced recovery after cardiac surgery typically emphasize minimal anxiolytic medication before or during surgery. (See  <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)"</a>.)</p><p class="headingAnchor" id="H2534224005"><span class="h1">MONITORING</span><span class="headingEndMark"> — </span>Cardiac surgery is conducted using standard American Society of Anesthesiologists (ASA) monitors  (<a class="graphic graphic_table graphicRef110080" href="/z/d/graphic/110080.html" rel="external">table 2</a>) [<a href="#rid1">1</a>], as well as intra-arterial and central venous access. We also monitor urine output, degree of neuromuscular blockade (using a peripheral nerve stimulator), and temperature.</p><p>Furthermore, for most cardiac surgical cases, we use transesophageal echocardiography (TEE), processed electroencephalography (EEG), and point-of-care (POC) testing of laboratory values. Additional monitoring with a pulmonary artery catheter (PAC) to monitor pulmonary artery pressure (PAP), cardiac output, and mixed venous oximetry, or a cerebral oximetry monitor may be employed in selected patients.</p><p class="headingAnchor" id="H2269497653"><span class="h2">Noninvasive standard monitors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standard noninvasive monitors </strong>– Prior to induction, we place standard noninvasive continuous monitors, including pulse oximetry (SaO<sub>2</sub>), electrocardiogram (ECG), and noninvasive blood pressure as a backup monitor for intra-arterial blood pressure. After endotracheal intubation, end-tidal carbon dioxide as well as airway pressure and volume measurements are continuously monitored.</p><p></p><p class="bulletIndent1">Both ECG leads II and V<sub>5</sub> are employed, with computerized ST-segment trending to facilitate optimal detection of myocardial ischemia, as in other patients with ischemic heart disease (see  <a class="medical medical_review" href="/z/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Monitoring for myocardial ischemia'</a>). In high-risk patients for whom pacing, defibrillation, or cardioversion may be necessary, defibrillator/pacing pads should be placed prior to anesthetic induction  (<a class="graphic graphic_figure graphicRef115417" href="/z/d/graphic/115417.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1">A peripheral nerve stimulator is positioned along the course of the facial nerve to intermittently elicit contraction of the orbicularis oris muscle for monitoring neuromuscular function. This ensures that appropriate muscle relaxation is maintained throughout the case. (See  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass", section on 'Maintenance of anesthesia and neuromuscular blockade'</a>.)</p><p></p><p class="headingAnchor" id="H156437650"><span class="h2">Other standard monitors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder catheter </strong>– A bladder catheter with a temperature probe is inserted after induction to measure urine output and core temperature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temperature monitors</strong> – Temperature is monitored at several sites (see  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass", section on 'Temperature'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A nasopharyngeal or tympanic membrane temperature probe is typically employed, particularly as a monitor of brain temperatures during cardiopulmonary bypass (CPB) and the weaning process [<a href="#rid2">2-4</a>]. However, the oxygenator arterial outlet temperature is the most reliable surrogate for cerebral temperature during cooling and rewarming [<a href="#rid2">2-5</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A bladder catheter with a temperature probe is used to monitor "core temperature"; a rectal temperature probe may be substituted if no urine output is expected (eg, in a patient with end-stage kidney disease). During the cooling and rewarming phases of CPB, bladder (or rectal) temperatures typically lag behind oxygenator, nasopharyngeal, tympanic membrane, and blood temperatures; thus, bladder temperature poorly reflects temperatures in the highly-perfused organs (eg, brain and kidneys) [<a href="#rid3">3,5</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If a PAC is inserted, pulmonary artery blood temperature is also monitored before and after CPB [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Point-of-care laboratory testing </strong>– Routine intraoperative laboratory point-of-care (POC) testing includes intermittent blood gas analysis, hemoglobin, electrolytes, calcium, glucose, activated whole blood clotting time (ACT), and in some institutions, other coagulation assays [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/1368.html" rel="external">"Clinical use of coagulation tests"</a>.)</p><p></p><p class="headingAnchor" id="H1004166944"><span class="h2">Intravascular cardiac monitors</span><span class="headingEndMark"> — </span>Cardiac surgery requires continuous monitoring of the cardiovascular system because:</p><p class="bulletIndent1"><span class="glyph">●</span>Critical cardiovascular disease (eg, coronary artery obstruction or cardiac valve lesions) necessitates close hemodynamic monitoring to avoid and rapidly correct myocardial ischemia or dysfunction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sudden and/or severe hemodynamic changes may occur due to mechanical manipulations during the surgical procedure itself.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Effects of anesthetic and pharmacologic manipulations of the cardiovascular system must be assessed rapidly.</p><p></p><p>The following cardiovascular monitors are typically employed:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intra-arterial catheter </strong>– An intra-arterial catheter is inserted before anesthetic induction for continuous monitoring of blood pressure and to facilitate intermittent blood sampling for specific POC tests during the operation. (See  <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">"Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation"</a>.)</p><p></p><p class="bulletIndent1">The radial artery is the most common cannulation site due to its superficial course, consistent accessibility, and redundant blood supply of the hand via the ulnar artery. If the cardiac surgical plan includes radial artery harvest, the contralateral radial artery or ulnar artery is also suitable. Despite concerns for hand ischemia or ulnar nerve injury (due to its proximity to the artery), complications associated with ulnar artery cannulation rarely occur [<a href="#rid8">8-11</a>]. Other alternative sites may be selected in some patients, including brachial, axillary, and femoral arteries. These more proximal monitoring sites have the advantage of providing better estimates of central aortic pressure, particularly following CPB, and complications are rare [<a href="#rid12">12,13</a>]. (See  <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">"Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation", section on 'Complications'</a>.)</p><p></p><p class="bulletIndent1">If an intraaortic balloon pump (IABP) is in place, intra-arterial blood pressure may be monitored at the tip of the balloon catheter in the descending thoracic aorta to avoid any delay in beginning surgery. Insertion of a peripheral intra-arterial catheter can then be accomplished as soon as possible after induction of anesthesia.</p><p></p><p class="bulletIndent1">If surgery on the aortic arch or repair of aortic dissection is planned, it may be necessary to obtain a second upper extremity intra-arterial catheter after induction. (See  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central venous catheter </strong>– A large-bore central venous catheter (CVC) is useful given the frequent need for infusion of vasoactive medications and the potential for high-volume administration of fluids or blood products. Typically, we cannulate the internal jugular vein using ultrasound guidance for vein localization  (<a class="graphic graphic_movie graphicRef113393" href="/z/d/graphic/113393.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef113394" href="/z/d/graphic/113394.html" rel="external">movie 2</a>) [<a href="#rid14">14,15</a>].</p><p></p><p class="bulletIndent1">We insert an introducer sheath such as a multi-lumen access catheter or sheath introducer (eg, Cordis) that functions as a large-caliber CVC and/or as a means to place a PAC, even if insertion of a PAC is not initially planned. Thus, if the patient becomes hemodynamically unstable in the postbypass or postoperative period, the introducer sheath facilitates later insertion of a PAC without interruption of vasoactive infusions. We typically insert the large-bore CVC shortly after induction of general anesthesia if there is adequate peripheral intravenous (IV) access for use during induction. Insertion after induction avoids patient discomfort due to pain and Trendelenburg positioning, which might result in hypertension, tachycardia, dyspnea, and myocardial ischemia in an awake patient. However, in a patient with difficult peripheral IV access or risk factors for hemodynamic instability during induction, we may insert the introducer sheath and/or PAC before induction of general anesthesia [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">In other institutions, the sheath introducer and CVC or PAC are routinely placed before induction in order to expedite surgical care. During large-bore CVC placement in an awake patient, small bolus doses of an anxiolytic agent (eg, <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 1 to 4 mg) and/or an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 50 to 150 mcg) may be judiciously administered to reduce patient discomfort.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary artery catheter</strong> – In selected patients, a PAC may be inserted to provide dynamic information regarding pulmonary artery pressure (PAP), cardiac output, and mixed venous oxygen saturation (SVO<sub>2</sub>) [<a href="#rid16">16-20</a>].</p><p></p><p class="bulletIndent1">We insert a PAC in patients with acute hemodynamic instability, preferably before induction of anesthesia or surgical incision [<a href="#rid16">16</a>]. Also, PAC monitoring is often employed in patients with moderate to severe pulmonary artery hypertension, reduced left ventricular (LV) ejection fraction (&lt;30 percent), severe coexisting pulmonary or kidney disease, planned coronary artery bypass grafting (CABG) surgery in combination with valve repair or replacement (due to longer CPB and aortic cross-clamp times that may result in increased potential for postbypass myocardial dysfunction), and in patients undergoing heart and/or lung transplantation. However, routine use is avoided in many centers because of absence of evidence for mortality benefit in cardiac surgical and other patient populations, as well as several potential risks [<a href="#rid21">21-27</a>]. (See  <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">"Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Complications'</a>.)</p><p></p><p class="bulletIndent1">Selection of the type of PAC to be inserted is based on institution-specific availability and preferences. We prefer a continuous cardiac output catheter with continuous mixed venous oximetry (SvO<sub>2</sub>) capabilities to facilitate management in the intensive care unit in the highest risk patients who have a greater likelihood of continued hemodynamic instability following surgery. (See  <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">"Pulmonary artery catheterization: Indications, contraindications, and complications in adults", section on 'Physiologic measurements'</a> and  <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">"Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock", section on 'Pulmonary artery catheterization'</a>.)</p><p></p><p class="headingAnchor" id="H2755696386"><span class="h2">Brain monitors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electroencephalography</strong> – We routinely employ a raw and/or processed electroencephalography (EEG) device (eg, a bispectral index monitor) [<a href="#rid28">28</a>]. Although such monitoring may help detect "light" anesthesia or awareness, EEG indices cannot reliably confirm that a patient is adequately anesthetized [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/400.html" rel="external">"Accidental awareness during general anesthesia"</a> and  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass", section on 'Maintenance of anesthesia and neuromuscular blockade'</a>.)</p><p></p><p class="bulletIndent1">Another use of EEG is to establish a neurophysiologic endpoint for the cerebral effects of cooling (electrocortical silence) in patients undergoing cardiac surgical procedures with deep hypothermia and circulatory arrest (DHCA) (see  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients", section on 'Electroencephalography'</a>). Furthermore, EEG data may supplement near-infrared spectroscopy (NIRS) to detect cerebral hypoperfusion [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebral oximetry</strong> – NIRS cerebral oximetry monitoring and maintenance of regional cerebral oxygen saturation (rSO<sub>2</sub>) within 20 percent of baseline may be employed to detect regional cerebral malperfusion events and intraoperative catastrophe. The algorithm describes management of significant decreases in rSO<sub>2</sub> during CPB  (<a class="graphic graphic_algorithm graphicRef108434" href="/z/d/graphic/108434.html" rel="external">algorithm 1</a>). A large retrospective multicenter cohort study from the Society of Thoracic Surgeons Adult Cardiac Surgery Database noted that adult cardiac surgical patients monitored with intraoperative cerebral oximetry had lower rates of major organ morbidity and mortality compared with those without such monitoring [<a href="#rid31">31</a>]. However, other meta-analyses of randomized trials have found there is insufficient evidence to recommend its universal use to reduce mortality or organ-specific morbidity [<a href="#rid32">32</a>]. For this reason, use of cerebral oximetry may be optimally used in selected patients such as those with significant cerebrovascular disease or other risk factors for neurologic or renal complications, and during selected procedures such as cardiac surgery with a concomitant procedure involving the ascending aorta or arch [<a href="#rid31">31,33</a>]. (See  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass", section on 'Neuromonitoring modalities'</a> and  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients", section on 'Cerebral oximetry'</a>.)</p><p></p><p class="headingAnchor" id="H3940854839"><span class="h1">TRANSESOPHAGEAL ECHOCARDIOGRAPHY</span></p><p class="headingAnchor" id="H3741570956"><span class="h2">Prebypass transesophageal echocardiography</span><span class="headingEndMark"> — </span>Practice guidelines of the American Society of Anesthesiologists (ASA) and Society of Cardiovascular Anesthesiologists suggest using transesophageal echocardiography (TEE) to confirm and refine preoperative diagnoses, detect new or unsuspected cardiovascular pathology that may alter anesthetic or surgical plans, as well as guide PAC insertion and final positioning [<a href="#rid34">34,35</a>]. Although useful for many types of cardiac surgical procedures, intraoperative TEE may have particularly important clinical benefits in patients undergoing cardiac valve repair or replacement or proximal aortic surgery [<a href="#rid36">36,37</a>]. In a retrospective cohort study that included 114,871 patients undergoing isolated coronary artery bypass grafting (CABG) surgery, intraoperative use of TEE was associated with lower 30-day mortality (3.7 versus 4.9 percent) or combined incidence of stroke and mortality (4.5 versus 5.5 percent) compared with no use of TEE [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Transesophageal echocardiography: General considerations'</a> and  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients", section on 'Transesophageal echocardiography'</a>.)</p><p></p><p>In the postbypass period, TEE is used to assess results of all surgical interventions while the patient is still in the operating room [<a href="#rid34">34</a>]. (See <a class="local">'Postbypass transesophageal echocardiography'</a> below.)</p><p>We conduct an initial comprehensive prebypass TEE examination, followed by continuous use of the TEE to monitor ventricular function and volume [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/5320.html" rel="external">"Transesophageal echocardiography: Indications, complications, and normal views"</a> and  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Components of a basic TEE examination (noncardiac surgery)'</a>.)</p><p>Even if TEE is not used electively, rapid deployment may be needed to diagnose causes of acute, persistent, and life-threatening hemodynamic instability (ie, "rescue" TEE). (See  <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">"Intraoperative rescue transesophageal echocardiography (TEE)"</a>.)</p><p class="headingAnchor" id="H2899774755"><span class="h3">Initial transesophageal echocardiography examination</span></p><p class="bulletIndent1"><span class="glyph">●</span>Global systolic LV function is assessed and ejection fraction is evaluated using a qualitative grading system (eg, mild, moderate, or severe global LV hypokinesia and systolic LV dysfunction) or estimated LV ejection fraction  (<a class="graphic graphic_movie graphicRef104531" href="/z/d/graphic/104531.html" rel="external">movie 3</a> and <a class="graphic graphic_movie graphicRef104144" href="/z/d/graphic/104144.html" rel="external">movie 4</a>). There is also some evidence for the use strain-based indices of LV dysfunction to predict adverse postbypass and postoperative outcomes [<a href="#rid40">40-42</a>]. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Global LV systolic function'</a> and  <a class="medical medical_review" href="/z/d/html/5294.html" rel="external">"Transesophageal echocardiography in the evaluation of the left ventricle", section on 'Systolic function'</a>.)</p><p></p><p class="bulletIndent1">The presence of spontaneous echo contrast in the left atrium (LA) or aorta indicates low cardiac output.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Global LV diastolic function is assessed using a quantitative grading system (grade 1, impaired relaxation; grade 2, pseudonormal; grade 3 restrictive filling)  (<a class="graphic graphic_diagnosticimage graphicRef110948" href="/z/d/graphic/110948.html" rel="external">image 1</a>). The pre-bypass evaluation of the diastolic function of the LV is most important for prognostic reasons rather than specific therapeutic interventions. Diastolic dysfunction has been shown to be associated with major adverse cardiac events, in-hospital mortality, and prolonged mechanical ventilation after cardiac surgery [<a href="#rid43">43-46</a>]. Details regarding a comprehensive assessment of diastolic function are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5304.html" rel="external">"Echocardiographic evaluation of left ventricular diastolic function in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It is also possible to obtain estimates of cardiac output using the LV outflow tract or aortic valve area combined with Doppler-based methods [<a href="#rid47">47</a>]. Such estimates may be particularly useful when thermodilution measurements of cardiac output are not available in the absence of a PAC. Details regarding calculation of hemodynamic parameters are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5296.html" rel="external">"Hemodynamics derived from transesophageal echocardiography", section on 'Cardiac output'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The LV is also assessed for regional wall motion abnormalities (RWMAs), characterized as hypokinesis, akinesis, or dyskinesis. These may be chronic (preexisting) or may be new changes, indicative of myocardial ischemia. RWMAs indicate specific territories of myocardium perfused by <strong>each of the major </strong>coronary arteries supplying the LV  (<a class="graphic graphic_figure graphicRef104112" href="/z/d/graphic/104112.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef104113" href="/z/d/graphic/104113.html" rel="external">figure 3</a>) [<a href="#rid48">48</a>]. In each of the 16 segments (17 minus the apical cap) of the LV wall, function may be graded as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Normal</p><p class="bulletIndent2"><span class="glyph">•</span>Hypokinetic (ie, reduced and delayed contraction)</p><p class="bulletIndent2"><span class="glyph">•</span>Akinetic (ie, absence of inward motion and thickening)</p><p class="bulletIndent2"><span class="glyph">•</span>Dyskinetic (ie, systolic thinning and outward systolic endocardial motion)</p><p></p><p class="bulletIndent1">Although rigorous quantitative grading of each myocardial segment is not typically performed during cardiac operations, a qualitative assessment of regional ventricular function is noted and recorded. Further details regarding TEE assessment of regional LV systolic function are available elsewhere. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Regional LV systolic function'</a> and  <a class="medical medical_review" href="/z/d/html/5294.html" rel="external">"Transesophageal echocardiography in the evaluation of the left ventricle", section on 'Evaluation of regional wall motion'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The LV is assessed for mural thrombus in patients who have an akinetic or dyskinetic myocardial segment, most commonly involving the ventricular apex  (<a class="graphic graphic_diagnosticimage graphicRef113396" href="/z/d/graphic/113396.html" rel="external">image 2</a> and <a class="graphic graphic_movie graphicRef113398" href="/z/d/graphic/113398.html" rel="external">movie 5</a> and <a class="graphic graphic_movie graphicRef113397" href="/z/d/graphic/113397.html" rel="external">movie 6</a>). (See  <a class="medical medical_review" href="/z/d/html/90.html" rel="external">"Left ventricular thrombus after acute myocardial infarction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RV function is assessed. Myocardial ischemia or exacerbation of pulmonary hypertension may cause severe RV dysfunction  (<a class="graphic graphic_movie graphicRef105882" href="/z/d/graphic/105882.html" rel="external">movie 7</a>). Some clinicians obtain strain measurements of RV dysfunction [<a href="#rid49">49</a>]. Details regarding a comprehensive assessment of the right heart are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/83974.html" rel="external">"Echocardiographic assessment of the right heart"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The thoracic aorta is evaluated for atheromatous disease, calcification, or dilatation prior to aortic cannulation, and cross-clamping  (<a class="graphic graphic_diagnosticimage graphicRef112683" href="/z/d/graphic/112683.html" rel="external">image 3</a>). Some centers also perform epiaortic scanning prior to aortic cannulation and cross-clamping  (<a class="graphic graphic_diagnosticimage graphicRef112683" href="/z/d/graphic/112683.html" rel="external">image 3</a>), either selectively or routinely, as a supplemental and possibly superior technique for identifying disease in the ascending aorta. Further discussion can be found in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass", section on 'Aortic cannulation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Structure and function of the four cardiac valves are assessed. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Valvular structure and function'</a>.)</p><p></p><p class="bulletIndent1">TEE can play an important role in determining the surgical plan in patients with cardiac valve disease (eg, confirming the preoperative diagnosis, decisions to repair versus replace a valve, or whether an additional valve requires repair). One study noted that TEE influenced cardiac surgical decisions in more than 9 percent of all patients, with the greatest observed impact in patients undergoing combined CABG and valve procedures [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1">Identification of significant aortic regurgitation (AR) is particularly important  (<a class="graphic graphic_movie graphicRef54254" href="/z/d/graphic/54254.html" rel="external">movie 8</a> and <a class="graphic graphic_diagnosticimage graphicRef79069" href="/z/d/graphic/79069.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef106988" href="/z/d/graphic/106988.html" rel="external">image 5</a> and <a class="graphic graphic_diagnosticimage graphicRef106998" href="/z/d/graphic/106998.html" rel="external">image 6</a>). AR may limit delivery of adequate antegrade cardioplegia solution into the coronary artery ostia after the ascending aorta is cross-clamped since much of the cardioplegia solution will regurgitate through the incompetent aortic valve back into the LV. This may cause distention of the LV as it fills. Management of patients with significant AR during CPB is addressed separately, including the possibility of inadequate delivery of antegrade cardioplegia and alternative options (eg, retrograde cardioplegia and/or insertion of an LV vent to maintain LV decompression) (see  <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">"Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Aortic regurgitation'</a>). Significant (more than mild) AR is also a relative contraindication to the placement of an IABP, since the degree of AR may be increased with diastolic balloon inflation during counterpulsation. (See  <a class="medical medical_review" href="/z/d/html/1482.html" rel="external">"Intraaortic balloon pump counterpulsation", section on 'Contraindications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The interatrial septum is interrogated for presence of a patent foramen ovale (PFO) or atrial septal defect [<a href="#rid51">51</a>]. This is accomplished using two-dimensional (2D) imaging, as well as color-flow Doppler imaging. If there is equivocal evidence of a PFO, confirmation by injection of IV agitated <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> contrast (known as a "bubble study") is a maneuver used to detect right to left atrial shunting through a PFO  (<a class="graphic graphic_movie graphicRef56656" href="/z/d/graphic/56656.html" rel="external">movie 9</a>). Transient atrial pressure reversal achieved with release of a sustained positive pressure breath may enhance sensitivity of this maneuver. Although repair of an incidentally discovered PFO is not warranted unless the surgical plan includes right atriotomy [<a href="#rid52">52</a>], its presence should be documented as useful information in case the patient suffers a future embolic stroke.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The LA and left atrial appendage (LAA) are assessed for thrombus, particularly in patients with current or past history of atrial fibrillation  (<a class="graphic graphic_movie graphicRef56080" href="/z/d/graphic/56080.html" rel="external">movie 10</a>). The finding of spontaneous echo contrast, indicative of stasis that predisposes to thrombus formation, is used to differentiate thrombi from normal variants such as a multilobed LAA or prominent trabeculations  (<a class="graphic graphic_movie graphicRef73470" href="/z/d/graphic/73470.html" rel="external">movie 11</a> and <a class="graphic graphic_movie graphicRef66795" href="/z/d/graphic/66795.html" rel="external">movie 12</a>). Identification of LA or LAA thrombus may lead to a decision to institute postoperative anticoagulation to reduce the risk of stroke. (See  <a class="medical medical_review" href="/z/d/html/5326.html" rel="external">"Echocardiographic evaluation of the atria and appendages", section on 'Transesophageal echocardiography'</a>.)</p><p></p><p class="headingAnchor" id="H2092047554"><span class="h3">Monitoring with transesophageal echocardiography</span><span class="headingEndMark"> — </span>Subsequently, throughout the prebypass period, and again during the postbypass period, we continuously monitor ventricular function and volume status. We monitor LV and RV function and filling. Goals include rapid detection and assessment of:</p><p class="bulletIndent1"><span class="glyph">●</span>New RWMAs (eg, hypokinesis, akinesis, or dyskinesis), which are highly suggestive of myocardial ischemia  (<a class="graphic graphic_figure graphicRef104112" href="/z/d/graphic/104112.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef104113" href="/z/d/graphic/104113.html" rel="external">figure 3</a>) [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Avoidance and treatment of ischemia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Development of hypovolemia or hypervolemia  (<a class="graphic graphic_movie graphicRef104149" href="/z/d/graphic/104149.html" rel="external">movie 13</a>). (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Volume status'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Development of low systemic vascular resistance as a cause of arterial hypotension. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Systemic vascular resistance'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Factors causing hypotension, including abnormalities in:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preload or volume status (ie, hypovolemia or hypervolemic congestive heart failure)</p><p class="bulletIndent2"><span class="glyph">•</span>Afterload or vascular resistance (ie, low systemic vascular resistance)</p><p class="bulletIndent2"><span class="glyph">•</span>Contractility or ventricular function (ie, poor LV or RV function)</p><p class="bulletIndent2"><span class="glyph">•</span>Valvular structure and function (ie, structural abnormalities or poor function)</p><p class="bulletIndent2"><span class="glyph">•</span>Other less common causes of hypotension, such as aortic dissection or cardiac tamponade</p><p></p><p class="headingAnchor" id="H3454577726"><span class="h3">Transesophageal echocardiography considerations for patients with COVID-19</span><span class="headingEndMark"> — </span>Since transesophageal echocardiography (TEE) examination is an aerosol-generating procedure, it should be avoided in patients with known or suspected novel coronavirus disease 2019 (COVID-19) unless the findings are likely to be critically important [<a href="#rid53">53-57</a>]. (See  <a class="medical medical_review" href="/z/d/html/5320.html" rel="external">"Transesophageal echocardiography: Indications, complications, and normal views", section on 'COVID-19 precautions'</a>.)</p><p>Thus, careful procedure-specific scrutiny is warranted regarding indications for TEE during cardiac or noncardiac surgery [<a href="#rid54">54</a>]. Examples of procedures for which TEE is usually warranted include:</p><p class="bulletIndent1"><span class="glyph">●</span>Type A aortic dissection.</p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial infarction with anatomical complications (eg, papillary muscle rupture, ventricular septal defect).</p><p class="bulletIndent1"><span class="glyph">●</span>Infective endocarditis with valvular and perivalvular involvement.</p><p class="bulletIndent1"><span class="glyph">●</span>Insertion of a ventricular support device.</p><p class="bulletIndent1"><span class="glyph">●</span>Need to diagnose acute, persistent, and life-threatening hemodynamic instability (ie, "rescue" TEE). (see  <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">"Intraoperative rescue transesophageal echocardiography (TEE)"</a>)</p><p></p><p>To reduce the risk of aerosolization, the airway should be secured prior to insertion of the TEE probe. Some centers employ a sheath for the TEE probe to further reduce the risk of provider and environmental contamination [<a href="#rid56">56</a>], and/or cover the ultrasound system (controls) with a plastic barrier. During TEE examination, airborne, contact, and droplet personal protective equipment (PPE) should be worn to prevent infection, which consists of an N95 or higher level respirator or powered air purifying respirator, eye protection (eg, goggles or face shield that goes around the side of the face), gloves, disposable gown, operating room cap, and shoe covers [<a href="#rid53">53-55,57</a>]. Additional precautions include minimizing the number of personnel performing TEE examination, limiting TEE use by performing a focused examination, and using dedicated TEE equipment for COVID-19-positive patients. (See  <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Considerations during aerosol-generating procedures'</a>.)</p><p>In some cases, alternative echocardiographic imaging modalities (eg, transthoracic echocardiography, point-of-care ultrasonography) may be considered. For example, transthoracic echocardiography may be employed immediately before and after the cardiac surgical procedure to confirm left ventricular (LV) and right ventricular (RV) function. (See  <a class="medical medical_review" href="/z/d/html/94583.html" rel="external">"Overview of perioperative uses of ultrasound"</a>.)</p><p class="headingAnchor" id="H3588939700"><span class="h1">INDUCTION OF GENERAL ANESTHESIA</span></p><p class="headingAnchor" id="H1697274836"><span class="h2">Induction techniques</span><span class="headingEndMark"> — </span>The goals of general anesthetic induction are to produce and maintain unconsciousness, attenuate the hemodynamic responses to endotracheal intubation and surgical stimulation, and prevent or treat hemodynamic changes that lead to myocardial oxygen imbalance and ischemia. Specific hemodynamic and physiologic goals for different types of cardiac disease (eg, coronary artery disease, cardiac valve lesions) are discussed in individual topics.</p><p>Regardless of the induction technique employed, hypotension may occur post-induction when a volatile inhalation anesthetic agent is administered to increase anesthetic depth in anticipation of the surgical incision. Hypotension occurs because of the long context-sensitive half time for high doses of an opioid such as <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> [<a href="#rid58">58</a>], and synergistic interaction of opioids with volatile agents (see  <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">"Maintenance of general anesthesia: Overview", section on 'Analgesic component: Opioid agents'</a>). Significant hypotension is avoided by reducing the dose of volatile agent, or treated by administering a vasopressor in small bolus doses (eg, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>) or as a low-dose infusion  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H973788980"><span class="h3">Balanced technique</span><span class="headingEndMark"> — </span>The most common anesthetic induction techniques for cardiac surgical patients includes use of a low dose of a sedative-hypnotic agent combined with a low dose of opioid and volatile anesthetic agent ("balanced technique"). For example, a small dose of <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> (eg, 0.5 to 1.5 mg/kg) may be administered in combination with a moderate dose of <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 2 to 4 mcg/kg and a neuromuscular blocking agent. Since a bolus injection of propofol typically produces dose-dependent hypotension due to venous and arterial dilation as well as decreased myocardial contractility, administration of a vasopressor such as <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> is often necessary. (See  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Propofol'</a>.)</p><p>Owing to its minimal hemodynamic side effects, <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> may be selected as the anesthetic induction agent for patients with cardiogenic shock, hemodynamic instability, critical left main coronary disease, severe aortic stenosis, or severe cardiomyopathy. A possible concern with the use of etomidate is that it inhibits the biosynthesis of cortisol, an effect that lasts &lt;24 hours following a single dose. Although this finding may not be clinically significant [<a href="#rid59">59</a>], etomidate is not routinely administered. (See  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Etomidate'</a>.)</p><p>A neuromuscular blocking agent is also administered during induction. During the few minutes required for adequate relaxation for endotracheal intubation, a volatile inhaled anesthetic is typically titrated to its effect on anesthetic depth. Anesthetic depth should be sufficient to assure unconsciousness and attenuate the sympathetic response to laryngoscopy and intubation. <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> 1 mg/kg intravenous (IV) is often included in the induction sequence to further blunt this sympathetic response. (See  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Lidocaine'</a> and  <a class="medical medical_review" href="/z/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Induction'</a>.)</p><p class="headingAnchor" id="H2880110011"><span class="h3">Higher-dose opioid technique</span><span class="headingEndMark"> — </span>An alternative induction technique that is used less commonly includes administration of a higher dose of a synthetic opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 10 to 25 mcg/kg) for patients who will remain intubated with controlled ventilation for several postoperative hours. This technique results in minimal direct myocardial depressant effect and only a small decrease in blood pressure. One important adverse side effect of high-dose opioid administration is chest wall rigidity, which may make ventilation difficult [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">"Perioperative uses of intravenous opioids in adults: General considerations", section on 'High-dose opioid induction technique'</a>.)</p><p class="headingAnchor" id="H3694166032"><span class="h2">Patient positioning</span><span class="headingEndMark"> — </span>Patients are typically in the supine position during cardiac surgery. The arms may either be tucked at the patient's side, or, less commonly, in an abducted position. A shoulder roll is typically placed under the scapulae to extend the neck. (See  <a class="medical medical_review" href="/z/d/html/94593.html" rel="external">"Patient positioning for surgery and anesthesia in adults", section on 'Supine'</a> and  <a class="medical medical_review" href="/z/d/html/94593.html" rel="external">"Patient positioning for surgery and anesthesia in adults", section on 'Particular concerns with the supine position'</a>.)</p><p>Patients are susceptible to positioning injuries during CABG surgery due to a prolonged duration in an unchanging position [<a href="#rid61">61</a>]. Theoretically, nonpulsatile flow and induced hypothermia during cardiopulmonary bypass (CPB), as well as intermittent hypotension during the prebypass and postbypass periods, may exacerbate nerve, skin, and other positioning injuries. Although there is no definitive evidence for the roles of these potential risk factors, extra precautions are taken to prevent such injuries. For example, the head is initially positioned on a cushioned pillow or "donut" pad, with frequent repositioning to prevent scalp ischemia and resultant occipital alopecia. If arms are tucked, the olecranon groove and fingers should be padded and protected from the metallic edge of the operating table to avoid pressure injuries. If arms are abducted, overextension beyond 90 degrees is avoided to prevent excessive tension on the pectoralis major muscle and brachial plexus injury [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/z/d/html/94593.html" rel="external">"Patient positioning for surgery and anesthesia in adults", section on 'Nerve injuries associated with supine positioning'</a>.)</p><p>After sternotomy, placement of a sternal retractor is necessary for harvesting the internal thoracic or internal mammary artery (see  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Incision, sternotomy, and harvesting of venous and arterial grafts'</a>). Retractor positioning is closely observed since the steel post attaching it to the operating table may compress the upper arm causing radial nerve injury and may also be associated with brachial plexus injury [<a href="#rid61">61-63</a>]. In addition, when the retractor lifts the sternum, the patient's head may be lifted off the supporting head cushion, particularly in an older patient who has cervical spine arthritis. If this occurs, the retractor should be adjusted or the patient's head should be repositioned with additional pillow support.</p><p class="headingAnchor" id="H4069973475"><span class="h2">Antibiotic prophylaxis</span><span class="headingEndMark"> — </span>Administration of antimicrobial therapy, typically a cephalosporin, should be initiated by the anesthesiologist within 60 minutes before the surgical incision, so that drug levels are optimal at the time of incision  (<a class="graphic graphic_table graphicRef76499" href="/z/d/graphic/76499.html" rel="external">table 4</a>). If <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">vancomycin</a> is selected for a patient with a beta-lactam penicillin allergy or one who is known to be colonized with methicillin-resistant <em>Staphylococcus aureus</em> (MRSA), administration should begin within 120 minutes before the incision because of the prolonged infusion time required. (See  <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Cardiac surgery'</a>.)</p><p class="headingAnchor" id="H4081926133"><span class="h1">MAINTENANCE OF GENERAL ANESTHESIA</span></p><p class="headingAnchor" id="H2526582327"><span class="h2">Maintenance techniques</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of anesthetic agents</strong> –<strong> </strong>During cardiac surgery, general anesthesia is typically maintained with a volatile anesthetic inhalation agent (ie, <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">isoflurane</a>, <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">desflurane</a>). Use of a total intravenous anesthetic (TIVA) technique during cardiac surgery, or combinations of volatile and intravenous agents are reasonable alternatives to maintain adequate depth of general anesthesia and prevent movement during surgery.</p><p></p><p class="bulletIndent1">A 2020 meta-analysis (42 trials, 8197 participants) comparing maintenance of anesthesia with volatile inhalation anesthetic agents versus TIVA techniques noted that inhalation agents were associated with lower one-year mortality and myocardial infarction (MI) [<a href="#rid64">64</a>]. A 2021 meta-analysis noted that volatile inhalation anesthetics were associated with shorter durations of intensive care unit stay (16 trials; 2003 participants) and hospital stay (12 trials; 1241 participants), but no differences in mortality or MI compared with TIVA [<a href="#rid64">64,65</a>]. Methodologic differences between these meta-analyses may account for the conflicting results [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthetic depth </strong>–<strong> </strong>Anesthetic requirements vary considerably during cardiac surgical procedures; thus, frequent adjustments of anesthetic depth are necessary. For example, in the prebypass period, severe pain and endogenous catecholamine release may occur during initial incision and particularly during sternotomy, necessitating adjustments to the depth of general anesthesia in order to prevent tachycardia and hypertension. Subsequently, during the periods of reduced surgical stimulation that typically follow sternotomy, it is appropriate to reduce anesthetic depth to avoid hypotension. (See  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Incision, sternotomy, and harvesting of venous and arterial grafts'</a>.)</p><p></p><p class="bulletIndent1">Notably, hypothermia and rewarming during CPB may considerably change anesthetic requirements [<a href="#rid67">67-69</a>]. Furthermore, some degree of hemodilution occurs with initiation of CPB, even when limited by autologous priming. Hemodilution expands the patient's volume of distribution for anesthetic and other drugs [<a href="#rid70">70</a>]. Thus, drugs such as neuromuscular blocking agents (NMBAs) that are primarily distributed within the intravascular space should be re-dosed when CPB is initiated, particularly if peripheral nerve stimulator monitoring shows a return of neuromuscular function. During CPB, neuromuscular function is monitored with a peripheral nerve stimulator. In contrast, re-dosing may not be necessary for agents with a large volume of distribution (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> and <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>) because of their rapid redistribution into the new larger intravascular volume [<a href="#rid70">70,71</a>].</p><p></p><p class="headingAnchor" id="H1579483771"><span class="h2">Prebypass ventilation strategies</span><span class="headingEndMark"> — </span>We use an intraoperative lung-protective ventilation strategy in the prebypass and postbypass period (with low tidal volume [TV], low driving pressure, and positive end-expiratory pressure [PEEP]) to potentially reduce the incidence of pulmonary complications. These ventilator settings are consistent with recommendations for lung-protective ventilation for all patients undergoing anesthesia and surgery with use of mechanical ventilation. Overdistention of the lungs should be avoided [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p>In a retrospective study that included 4694 patients undergoing cardiac surgery with CPB, 10.9 percent experienced pulmonary complications in the postoperative period (pneumonia, prolonged mechanical ventilation, need for reintubation, and/or poor oxygenation with a ratio of arterial oxygen tension/fraction of inspired oxygen &lt;100 mmHg within 48 postoperative hours while intubated) [<a href="#rid73">73</a>]. Fewer pulmonary complications were noted in patients managed with lung-protective ventilation that included TV &lt;8 mL/kg ideal body weight, modified driving pressure (peak inspiratory pressure - PEEP) &lt;16 cmH<sub>2</sub>O, and PEEP ≥5 cmH<sub>2</sub>O, compared with patients managed with other ventilation strategies (adjusted odds ratio [OR] 0.56, 95% CI 0.42-0.75). A sensitivity analysis revealed that use of modified driving pressure &lt;16 mmHg, but not PEEP or low TV, was also independently associated with fewer pulmonary complications (adjusted OR 0.51, 95% CI 0.39-0.66) [<a href="#rid73">73</a>]. Although elevated driving pressure may simply be a marker (rather than a cause) of lung injury, we maintain this pressure &lt;16 mmHg as a component of lung-protective ventilation after CPB. A separate retrospective study that included 9359 cardiac surgical patients has noted that lower tidal volume (6.8 ± 1.3 mL/kg) was associated with very modest improvement in postoperative oxygenation, compared with moderate (7.9 ± 0.3) or higher (9.5 ± 0.9) tidal volumes [<a href="#rid74">74</a>].</p><p>During the prebypass period, it may be necessary to make frequent adjustments in ventilation to accommodate changing surgical conditions. Notably, during sternotomy ventilation is briefly interrupted to prevent lung injury from the sternal saw. During subsequent internal mammary artery harvest, some surgeons request reduction in the tidal volume (TV) to avoid suboptimal surgical exposure due to interference from the lungs during inspiration. In these instances, respiratory rate is increased to maintain adequate alveolar ventilation.</p><p class="headingAnchor" id="H1733731373"><span class="h2">Prebypass fluid management</span><span class="headingEndMark"> — </span>Prior to CPB, fluid administration (usually with a balanced crystalloid solution rather than a colloid solution) is typically restricted to the small volumes necessary to administer IV medications because initiation of CPB results in significant hemodilution as the CPB circuit prime (up to 1.5 liters of crystalloid) mixes with the patient's blood volume. However, judicious IV volume expansion, or administration of a vasopressor infusion, may be necessary to maintain hemodynamic stability in response to blood loss or hypovolemia in the prebypass period. Excessive hemodilution is avoided during cardiac surgery with or without CPB due to risks for postoperative weight gain, increased use of blood products, delirium, and longer durations of controlled mechanical ventilation and hospital stay [<a href="#rid75">75,76</a>]. (See  <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass", section on 'Avoiding excessive fluid administration'</a> and  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Off-pump coronary artery bypass surgery'</a>.)</p><p>Hydroxyethyl starch (HES) colloid solutions are avoided due to concerns regarding impairment of hemostasis and acute kidney injury (AKI) [<a href="#rid77">77-82</a>]. In a 2012 meta-analysis of randomized trials in cardiac surgical patients receiving HES solutions, risk of reoperation for bleeding was more than doubled (relative risk [RR] 2.24, 95% CI 1.14-4.40) compared with albumin [<a href="#rid80">80</a>]. In that meta-analysis, postoperative blood loss and transfusions of red cells, fresh frozen plasma, and platelets were all increased in patients receiving HES. One retrospective study in cardiac surgical patients noted that patients receiving a HES 130/0.4 solution for intraoperative fluid therapy, including use in the CPB pump prime, were twice as likely to develop AKI compared with those receiving a balanced crystalloid solution [<a href="#rid77">77</a>]. However, data are not consistent, and some studies in other surgical populations have noted no differences in risk for AKI or other serious postoperative complications in patients receiving HES solution compared with other types of fluids [<a href="#rid83">83-88</a>]. (See  <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Hydroxyethyl starches'</a>.)</p><p>Transfusion of red blood cells is uncommon prior to CPB but may be necessary in response to sudden blood loss, or while preparing for initiation of CPB in patients with severe anemia.</p><p>Urine output is measured before CPB, confirming proper placement of the Foley catheter and adequate bladder drainage, and subsequently as a gross indicator of renal perfusion and function. Effects of anesthesia and surgery typically reduce glomerular filtration and tubular function and may reduce urine output in the prebypass period [<a href="#rid89">89</a>]. Urine output is also monitored during CPB as a surrogate for end-organ perfusion.</p><p>Remote ischemic preconditioning (RIPC), the application of repeated cycles of blood flow restriction typically in an upper extremity, has shown some association with reduced incidence of AKI, particularly with concurrent volatile anesthesia use [<a href="#rid90">90,91</a>].</p><p class="headingAnchor" id="H239913895"><span class="h1">PREPARATIONS FOR CARDIOPULMONARY BYPASS</span><span class="headingEndMark"> — </span>Prior to initiating cardiopulmonary bypass (CPB), several key steps must be completed, as noted in separate topics  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic anticoagulation</strong> – Systemic anticoagulation is necessary before aortic cannulation and subsequent initiation of CPB. Typically, this is accomplished with an intravenous (IV) dose of heparin 300 to 400 units/kg, with confirmation of adequacy of systemic anticoagulation to prevent clot formation in the CPB circuit. Details regarding heparin administration and monitoring are available in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass", section on 'Systemic anticoagulation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antifibrinolytic administration</strong> – Prophylactic antifibrinolytic therapy using a lysine analog (eg, epsilon-aminocaproic acid [EACA] or <a class="drug drug_general" data-topicid="10011" href="/z/d/drug information/10011.html" rel="external">tranexamic acid</a> [TXA]) is typically administered shortly after systemic heparinization to decrease microvascular bleeding in the postbypass period. Details are available in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass", section on 'Antifibrinolytic administration'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cannulation of the great vessels</strong> – To initiate CPB, aortic and venous cannulation are necessary to divert the patient's blood from the heart and lungs, with rerouting to the extracorporeal circuit. (See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass", section on 'Aortic, venous, and coronary sinus cannulation'</a>.)</p><p></p><p class="headingAnchor" id="H668450594"><span class="h1">MANAGEMENT OF CARDIOPULMONARY BYPASS</span><span class="headingEndMark"> — </span>Initiation of cardiopulmonary bypass (CPB), management during CPB, and weaning from CPB are discussed in separate topics  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/90614.html" rel="external">"Weaning from cardiopulmonary bypass"</a>.)</p><p></p><p class="headingAnchor" id="H4114375535"><span class="h1">MANAGEMENT DURING THE POSTBYPASS PERIOD</span><span class="headingEndMark"> — </span>Key steps for any cardiac surgical procedure in the period immediately after cardiopulmonary bypass (CPB) include venous and arterial decannulation and reversal of anticoagulation with protamine administration  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>) (see  <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass", section on 'Reversal of anticoagulation activity'</a>). Residual pump blood is reinfused, and temporary or backup epicardial pacing wires are inserted.</p><p class="headingAnchor" id="H1584645758"><span class="h2">Management of cardiovascular problems</span><span class="headingEndMark"> — </span>Cardiovascular problems that result in hemodynamic instability are identified and treated  (<a class="graphic graphic_table graphicRef93595" href="/z/d/graphic/93595.html" rel="external">table 5</a> and <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass", section on 'Cardiovascular problems'</a>.)</p><p>Similar cardiovascular problems may be encountered after cardiac surgical repairs accomplished without the aid of CPB (eg, off-pump coronary artery bypass grafting [CABG] surgery). (See  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Off-pump coronary artery bypass surgery'</a>.)</p><p class="headingAnchor" id="H3745046965"><span class="h2">Postbypass management of fluids and blood products</span><span class="headingEndMark"> — </span>After weaning from CPB, intravascular volume status is reevaluated with transesophageal echocardiography (TEE) assessments (see <a class="local">'Postbypass transesophageal echocardiography'</a> below), with consideration of hemodynamic parameters such as blood pressure, central venous pressure (CVP), pulmonary artery pressure (PAP), cardiac output, and mixed venous oxygen saturation (SvO<sub>2</sub>). Serial lactate and/or base deficit values on arterial blood gases can also be useful to guide fluid therapy. Fluid administration may be necessary due to treat hypovolemia, or transfusion of red blood cells may be necessary due to persistent surgical bleeding. Decisions regarding transfusion are individualized, but hemoglobin is typically maintained ≥7.5 g/dL [<a href="#rid92">92-96</a>]. (See  <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass", section on 'Transfusion of red blood cells'</a>.)</p><p class="headingAnchor" id="H3955425563"><span class="h2">Management of other systemic problems</span><span class="headingEndMark"> — </span>Other systemic complications (eg, pulmonary, metabolic, renal) are frequently encountered immediately after weaning from CPB while the patient is still in the operating room. These problems are often predictable based on patient-specific and cardiac surgical procedure-specific factors. However, some patients experience unpredictable, sudden, or severe complications that require immediate intervention and/or urgent reinstitution of CPB. Management of these problems is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass"</a>.)</p><p class="headingAnchor" id="H2274276490"><span class="h2">Postbypass transesophageal echocardiography</span><span class="headingEndMark"> — </span>TEE examination immediately after cardiac surgery emphasizes the following aspects [<a href="#rid39">39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Adequacy of any surgical repair (eg, repair or replacement of a cardiac valve) is assessed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Global left ventricular (LV) and right ventricular (RV) function are evaluated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LV and RV chamber sizes are assessed to determine intravascular volume status  (<a class="graphic graphic_movie graphicRef104149" href="/z/d/graphic/104149.html" rel="external">movie 13</a>). This is important because CVP and PAP measurements are poor predictors of intravascular volume and fluid responsiveness [<a href="#rid97">97</a>]. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Volume status'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LV regional wall motion abnormalities (RWMAs) are documented as part of the overall assessment of the adequacy of revascularization in territories of myocardium perfused by each of the major coronary arteries supplying the LV  (<a class="graphic graphic_figure graphicRef104112" href="/z/d/graphic/104112.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef104113" href="/z/d/graphic/104113.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery", section on 'Postbypass transesophageal echocardiography'</a>.)</p><p></p><p class="bulletIndent1">Previously ischemic or hibernating myocardium may show improved function in the early postbypass period. However, myocardial stunning is common and consequently, myocardial segments that had abnormal contraction in the prebypass period may remain impaired even after adequate coronary blood flow has been restored.</p><p></p><p class="bulletIndent1">Significant deterioration of regional wall motion in previously normal myocardial segments may indicate a technical problem with a coronary graft (eg, poor quality of a bypass graft anastomosis, kinking, vasospasm, or embolization of air or microparticulate debris into the graft)  (<a class="graphic graphic_movie graphicRef109762" href="/z/d/graphic/109762.html" rel="external">movie 14</a>). Poor graft flow can be confirmed by a Doppler flow probe applied to the graft. ST-segment changes on the electrocardiogram (ECG) or hypotension with low cardiac output may also be noted. Detection of such problems allows surgical correction prior to leaving the operating room. (See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass", section on 'Surgical or technical problems'</a>.)</p><p></p><p class="bulletIndent1">In patients who require ventricular pacing after CPB, a distinct septal motion abnormality termed "septal bounce" is often observed; this occurs due to the abnormal pattern of ventricular depolarization that accompanies RV epicardial pacing  (<a class="graphic graphic_movie graphicRef109763" href="/z/d/graphic/109763.html" rel="external">movie 15</a>). Septal bounce can be distinguished from a true RWMA because septal thickening persists during ventricular pacing but is absent when the septum is ischemic. If this is difficult to discern visually, a brief pause in ventricular pacing may be helpful.</p><p></p><p class="bulletIndent1">New or worsening mitral regurgitation (MR) in the postbypass period should prompt a thorough evaluation for LV RWMAs indicating an ischemic cause of the MR.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypotension after cardiac surgical procedures may occasionally be caused by dynamic LV outflow tract obstruction with systolic anterior motion of the mitral leaflets [<a href="#rid98">98</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If aortic dissection is suspected following decannulation (eg, in a patient with a calcific or diffusely atheromatous ascending aorta, or one who develops postbypass hypotension that is unresponsive to treatment), the ascending aorta is evaluated to identify this potentially fatal complication  (<a class="graphic graphic_diagnosticimage graphicRef108394" href="/z/d/graphic/108394.html" rel="external">image 7</a>).</p><p></p><p>TEE is also used for continuous monitoring throughout the postbypass period to assess ventricular volume and function, and to aid diagnosis of hypotension. The TEE probe is left in place until the patient is ready for transport to the intensive care unit.</p><p class="headingAnchor" id="H3896918182"><span class="h2">Postbypass ventilation</span><span class="headingEndMark"> — </span>As noted above, we use an intraoperative lung-protective ventilation strategy in the prebypass and postbypass period (with low tidal volume [TV], low driving pressure, and positive end-expiratory pressure [PEEP]) to potentially reduce the incidence of pulmonary complications [<a href="#rid73">73,74</a>]. (See <a class="local">'Prebypass ventilation strategies'</a> above and  <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p class="headingAnchor" id="H1674916702"><span class="h2">Sternotomy closure</span><span class="headingEndMark"> — </span>Hemostasis must be achieved prior to closure of the sternotomy wound. Management of bleeding and coagulopathy in the postbypass period can be challenging, as discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass", section on 'Achieving hemostasis and management of bleeding'</a>.)</p><p>With chest closure, it is common to see minor decreases in arterial blood pressure with concomitant increases in CVP and/or PAP. This occurs due to cardiac chamber compression as the sternum is reapproximated. TEE is employed to verify that hypotension is not the result of new RWMAs that may result from kinking or occlusion of a newly placed bypass graft.</p><p>In rare cases, sternal closure is not possible due to persistent bleeding, hemodynamic instability caused by compression of the right atrium and ventricle, or other technical problems. In these instances, an Esmarch bandage is sutured to the open sternal edges to "close" the wound prior to leaving the operating room. (See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass", section on 'Inability to close the sternum'</a>.)</p><p class="headingAnchor" id="H3404858099"><span class="h2">Transport and handoff in the intensive care unit</span></p><p class="headingAnchor" id="H704066042"><span class="h3">Preparation for transport</span><span class="headingEndMark"> — </span>Optimal patient condition for transport to the intensive care unit (ICU) is ensured as surgery concludes (eg, hemodynamic stability, control of bleeding and coagulopathy, adequate oxygenation and ventilation). A final arterial blood gas is obtained to assess PaO<sub>2</sub> and base deficit, and point-of-care tests are obtained to check hemoglobin (Hgb), potassium, and calcium levels. A final transesophageal echocardiography (TEE) evaluation of ventricular function and volume status is performed, and appropriate adjustments in inotropic, vasodilator, or fluid therapy are made.</p><p>If there is clinical evidence for ongoing hemodynamic instability evidenced by refractory hypotension, low measured cardiac index, metabolic acidosis, persistent electrocardiogram (ECG) changes (particularly ST-segment elevation), or significant deterioration in regional or global left ventricular (LV) or right ventricular (RV) function noted with TEE, then we often insert a pulmonary artery catheter (PAC) before the patient leaves the operating room. The continuous hemodynamic data provided by a PAC may be useful for ongoing resuscitation in the ICU since continuous TEE monitoring will no longer be available in the postoperative period. PAC placement under controlled conditions in the operating room is preferred to urgent or emergency placement in an unstable patient after transport to the ICU. Risks during insertion include inducing ventricular fibrillation, particularly in patients with active RV ischemia [<a href="#rid99">99</a>].</p><p>Continuous infusion of an intravenous (IV) sedative such as <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">dexmedetomidine</a> is initiated before discontinuing the volatile inhalation anesthetic. Adequate time for the selected IV agent to reach steady plasma concentrations should be allowed in the final minutes before leaving the operating room so that the patient remains adequately sedated during transport. (See  <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">"Monitored anesthesia care in adults", section on 'Propofol'</a> and  <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">"Monitored anesthesia care in adults", section on 'Dexmedetomidine'</a>.)</p><p class="headingAnchor" id="H3808483001"><span class="h3">Transport to the intensive care unit</span><span class="headingEndMark"> — </span>Details regarding transport to the intensive care unit are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">"Transport of surgical patients"</a> and  <a class="medical medical_review" href="/z/d/html/119347.html" rel="external">"Transport of surgical patients", section on 'Considerations for critically ill patients'</a>.)</p><p>In rare cases, direct transport to a cardiac catheterization suite for emergency coronary angiography may be necessary after cardiac surgery (eg, if acute coronary ischemia is suspected or if hemodynamic instability of unclear etiology persists) [<a href="#rid100">100</a>].</p><p class="headingAnchor" id="H2349515638"><span class="h3">Handoff in the intensive care unit</span><span class="headingEndMark"> — </span>Upon arrival in the ICU, patient information is communicated from the surgical team to the ICU team using a formal process that is termed a "handoff," or "handover." The table outlines one suggested handover protocol  (<a class="graphic graphic_table graphicRef94973" href="/z/d/graphic/94973.html" rel="external">table 6</a>) [<a href="#rid101">101-103</a>]. In all cases, the anesthesiologist should remain with the patient until hemodynamic and overall stability are ensured. (See  <a class="medical medical_review" href="/z/d/html/94586.html" rel="external">"Handoffs of surgical patients", section on 'Operating room to intensive care unit'</a>.)</p><p>In a 2018 literature review of 21 studies (4568 patients), a structured interdisciplinary handover from the operating room to the ICU after cardiac surgery was associated with prevention of adverse events (seven studies), as well as with improved provider satisfaction (13 studies), handoff completeness (18 studies), and compliance with process measures such as efficiency in transfer of equipment and technology and handoff of critical information, compared with unstructured handoffs [<a href="#rid104">104</a>].</p><p class="headingAnchor" id="H3141982262"><span class="h1">EMERGENCY CARDIAC SURGICAL PROCEDURES</span><span class="headingEndMark"> — </span>Patients requiring emergency surgery have a high risk for morbidity and mortality [<a href="#rid16">16,105-108</a>]. (See  <a class="medical medical_review" href="/z/d/html/94291.html" rel="external">"Preoperative evaluation for anesthesia for cardiac surgery", section on 'Emergency surgery'</a> and  <a class="medical medical_review" href="/z/d/html/94292.html" rel="external">"Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients", section on 'Preanesthetic assessment and planning'</a>.)</p><p>Considerations for emergency or high-risk cases include:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with actual or potential hemodynamic instability may present to the operating room with an intraaortic balloon pump (IABP) in place, or the surgeon may plan to insert an IABP after induction of general anesthesia or before termination of cardiopulmonary bypass (CPB). Notably, an IABP is contraindicated if the patient has significant aortic regurgitation (AR). (See  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Prebypass TEE assessment'</a> and  <a class="medical medical_review" href="/z/d/html/1482.html" rel="external">"Intraaortic balloon pump counterpulsation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All monitoring should be established before (rather than after) anesthetic induction if possible, including insertion of the intra-arterial catheter and placement of a central venous catheter (CVC).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>External defibrillator pads should be placed on the patient prior to induction, and a functioning pacemaker/defibrillator should be ready at the bedside. If atrial or ventricular fibrillation occur, appropriate and immediate cardioversion or defibrillation is typically necessary unless the surgical team can rapidly insert arterial and venous cannulae to initiate CPB.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In some cases, prepping and draping in preparation for surgery should be completed while the patient is still awake, with the entire operating room team present and ready to urgently establish CPB if cardiac arrest occurs during anesthetic induction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inotropic and vasopressor infusions should be connected in the CVC ports, ready to infuse.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Induction of anesthesia is performed with agents that cause minimal change in hemodynamics. Examples include <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> 0.3 mg/kg or <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 5 to 10 mcg/kg combined with <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 0.05 to 0.1 mg/kg. Anesthesia is subsequently maintained during the prebypass period with appropriate doses of volatile inhalation anesthetic.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemodynamic stability is carefully maintained during the prebypass period. Typically, vasoactive drug infusions are required to maintain adequate blood pressure and cardiac output  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 3</a>). Atrial pacing may be necessary to establish optimum heart rate, or atrioventricular (AV) pacing may be necessary if heart block is present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CPB is established as quickly as possible. (See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postbypass problems should be anticipated, as noted below after surgery for each lesion. (See  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass"</a> and  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Postbypass management'</a> and  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Postbypass management'</a> and  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Postbypass management'</a> and  <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery", section on 'Postbypass management'</a>.)</p><p></p><p class="headingAnchor" id="H2849277144"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118172.html" rel="external">"Society guideline links: Management of cardiopulmonary bypass"</a>.)</p><p class="headingAnchor" id="H675232393"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Premedication </strong>–<strong> </strong>Some cardiac surgical patients benefit from premedication with small incremental doses of a short-acting intravenous (IV) benzodiazepine (eg, <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 1 to 2 mg) and/or opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 50 mcg), administered under the anesthesiologist's observation. However, titration of smaller doses is warranted in older patients with critical cardiac lesions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring </strong>–<strong> </strong>Cardiac surgery is conducted using standard American Society of Anesthesiologists (ASA) monitors  (<a class="graphic graphic_table graphicRef110080" href="/z/d/graphic/110080.html" rel="external">table 2</a>), as well as intra-arterial and central venous access. We also monitor urine output, degree of neuromuscular blockade (using a peripheral nerve stimulator), and temperature. Furthermore, for most cardiac surgical cases, we use transesophageal echocardiography (TEE), processed electroencephalography (EEG), and point-of-care (POC) testing of laboratory values. Additional monitoring with a pulmonary artery catheter (PAC) or a cerebral oximetry monitor may be employed in selected patients. (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>TEE considerations </strong>–<strong> </strong>Intraoperative TEE is often used during cardiac surgery to confirm and refine preoperative diagnoses, detect new or unsuspected cardiovascular pathology that may alter anesthetic or surgical plans, and guide PAC positioning. We conduct an initial comprehensive prebypass TEE examination, followed by continuous use of the TEE to monitor ventricular function and volume. In the postbypass period, TEE is used to assess results of all surgical interventions while the patient is still in the operating room. Even if TEE is not used electively, rapid deployment may be needed to diagnose causes of acute, persistent, and life-threatening hemodynamic instability (ie, "rescue" TEE). (See <a class="local">'Prebypass transesophageal echocardiography'</a> above and <a class="local">'Postbypass transesophageal echocardiography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction of anesthesia </strong>–<strong> </strong>The most common anesthetic induction technique includes use of a low dose of a sedative-hypnotic agent combined with a low dose of opioid and volatile anesthetic agent ("balanced technique"). Administration of higher doses of a synthetic opioid is avoided in patients participating in enhanced recovery after cardiac surgery (ERACS) protocols to avoid prolonged respiratory depression and need for mechanical ventilation. (See <a class="local">'Induction techniques'</a> above and  <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maintenance of anesthesia </strong>–<strong> </strong>We suggest maintenance of general anesthesia with a volatile anesthetic agent (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Use of a total intravenous anesthetic (TIVA) technique or combinations of volatile and intravenous agents are reasonable alternatives to maintain adequate anesthetic depth and prevent movement during surgery. Neuromuscular function is monitored with a peripheral nerve stimulator during CPB. (See <a class="local">'Maintenance techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung-protective ventilation </strong>–<strong> </strong>We use a lung-protective ventilation strategy before and after cardiopulmonary bypass (CPB) with low tidal volume [TV], low driving pressure, and positive end-expiratory pressure [PEEP]) to potentially reduce the incidence of pulmonary complications. (See <a class="local">'Prebypass ventilation strategies'</a> above and <a class="local">'Postbypass ventilation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fluid management </strong>–<strong> </strong>Judicious fluid administration (usually with a balanced crystalloid solution rather than a colloid solution) prior to CPB is typically restricted to small volumes because initiation of CPB results in significant hemodilution as the CPB circuit prime mixes with the patient's blood volume. We suggest avoiding hydroxyethyl starch (HES) colloid solutions (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>), due to concerns regarding increased risk of bleeding and transfusion, and possibly acute kidney injury (AKI). After weaning from CPB and return of reservoir pump blood, intravascular volume status is reevaluated and treated. Decisions regarding transfusion of blood products are individualized, but hemoglobin is typically maintained ≥7.5 g/dL. (See  <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Choosing fluid: Crystalloid, colloid, or blood'</a> and <a class="local">'Prebypass fluid management'</a> above and <a class="local">'Postbypass management of fluids and blood products'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management during CPB </strong>–<strong> </strong>Key steps for intraoperative management of CPB are noted in the table  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>), and are discussed in detail in separate topics:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">"Initiation of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/90614.html" rel="external">"Weaning from cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management after CPB </strong>–<strong> </strong>Key steps for the period immediately after CPB are noted in the  (<a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">table 1</a>). Cardiovascular and other systemic problems in the postbypass period are identified and treated  (<a class="graphic graphic_table graphicRef93595" href="/z/d/graphic/93595.html" rel="external">table 5</a>). (See <a class="local">'Management during the postbypass period'</a> above and  <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">"Intraoperative problems after cardiopulmonary bypass"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency or high-risk procedures </strong>–<strong> </strong>Considerations for emergency or high-risk cardiac surgical procedures are discussed above. (See <a class="local">'Emergency cardiac surgical procedures'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Society of Anesthesiologists. Standards for Basic Anesthetic Monitoring. www.asahq.org/Search.aspx?q=standards+basic+anesthetic+monitoring (Accessed on March 29, 2016).</li><li><a class="nounderline abstract_t">Engelman R, Baker RA, Likosky DS, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management during Cardiopulmonary Bypass. J Extra Corpor Technol 2015; 47:145.</a></li><li><a class="nounderline abstract_t">Engelman R, Baker RA, Likosky DS, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass. Ann Thorac Surg 2015; 100:748.</a></li><li><a class="nounderline abstract_t">Saad H, Aladawy M. Temperature management in cardiac surgery. Glob Cardiol Sci Pract 2013; 2013:44.</a></li><li><a class="nounderline abstract_t">Nussmeier NA, Cheng W, Marino M, et al. Temperature during cardiopulmonary bypass: the discrepancies between monitored sites. Anesth Analg 2006; 103:1373.</a></li><li><a class="nounderline abstract_t">Akata T, Setoguchi H, Shirozu K, Yoshino J. Reliability of temperatures measured at standard monitoring sites as an index of brain temperature during deep hypothermic cardiopulmonary bypass conducted for thoracic aortic reconstruction. J Thorac Cardiovasc Surg 2007; 133:1559.</a></li><li><a class="nounderline abstract_t">Rhee AJ, Kahn RA. Laboratory point-of-care monitoring in the operating room. Curr Opin Anaesthesiol 2010; 23:741.</a></li><li><a class="nounderline abstract_t">Kedev S, Zafirovska B, Dharma S, Petkoska D. Safety and feasibility of transulnar catheterization when ipsilateral radial access is not available. Catheter Cardiovasc Interv 2014; 83:E51.</a></li><li><a class="nounderline abstract_t">Lanspa TJ, Williams MA, Heirigs RL. Effectiveness of ulnar artery catheterization after failed attempt to cannulate a radial artery. Am J Cardiol 2005; 95:1529.</a></li><li><a class="nounderline abstract_t">Gokhroo R, Kishor K, Ranwa B, et al. Ulnar Artery Interventions Non-Inferior to Radial Approach: AJmer Ulnar ARtery (AJULAR) Intervention Working Group Study Results. J Invasive Cardiol 2016; 28:1.</a></li><li><a class="nounderline abstract_t">Mangin L, Bertrand OF, De La Rochellière R, et al. The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients. J Invasive Cardiol 2005; 17:77.</a></li><li><a class="nounderline abstract_t">Bazaral MG, Welch M, Golding LA, Badhwar K. Comparison of brachial and radial arterial pressure monitoring in patients undergoing coronary artery bypass surgery. Anesthesiology 1990; 73:38.</a></li><li><a class="nounderline abstract_t">Singh A, Bahadorani B, Wakefield BJ, et al. Brachial Arterial Pressure Monitoring during Cardiac Surgery Rarely Causes Complications. Anesthesiology 2017; 126:1065.</a></li><li><a class="nounderline abstract_t">Practice Guidelines for Central Venous Access 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology 2020; 132:8.</a></li><li><a class="nounderline abstract_t">Bodenham Chair A, Babu S, Bennett J, et al. Association of Anaesthetists of Great Britain and Ireland: Safe vascular access 2016. Anaesthesia 2016; 71:573.</a></li><li><a class="nounderline abstract_t">Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:e652.</a></li><li><a class="nounderline abstract_t">Bignami E, Belletti A, Moliterni P, et al. Clinical practice in perioperative monitoring in adult cardiac surgery: is there a standard of care? Results from an national survey. J Clin Monit Comput 2016; 30:347.</a></li><li><a class="nounderline abstract_t">Kastrup M, Markewitz A, Spies C, et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand 2007; 51:347.</a></li><li><a class="nounderline abstract_t">Brovman EY, Gabriel RA, Dutton RP, Urman RD. Pulmonary Artery Catheter Use During Cardiac Surgery in the United States, 2010 to 2014. J Cardiothorac Vasc Anesth 2016; 30:579.</a></li><li><a class="nounderline abstract_t">Judge O, Ji F, Fleming N, Liu H. Current use of the pulmonary artery catheter in cardiac surgery: a survey study. J Cardiothorac Vasc Anesth 2015; 29:69.</a></li><li><a class="nounderline abstract_t">Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294:1625.</a></li><li><a class="nounderline abstract_t">Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366:472.</a></li><li><a class="nounderline abstract_t">Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5.</a></li><li><a class="nounderline abstract_t">Xu F, Wang Q, Zhang H, et al. Use of pulmonary artery catheter in coronary artery bypass graft. Costs and long-term outcomes. PLoS One 2015; 10:e0117610.</a></li><li><a class="nounderline abstract_t">Whitener S, Konoske R, Mark JB. Pulmonary artery catheter. Best Pract Res Clin Anaesthesiol 2014; 28:323.</a></li><li><a class="nounderline abstract_t">Gidwani UK, Mohanty B, Chatterjee K. The pulmonary artery catheter: a critical reappraisal. Cardiol Clin 2013; 31:545.</a></li><li><a class="nounderline abstract_t">Youssef N, Whitlock RP. The Routine Use of the Pulmonary Artery Catheter Should Be Abandoned. Can J Cardiol 2017; 33:135.</a></li><li><a class="nounderline abstract_t">Kertai MD, Whitlock EL, Avidan MS. Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery. Anesth Analg 2012; 114:533.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists Task Force on Intraoperative Awareness. Practice advisory for intraoperative awareness and brain function monitoring: a report by the american society of anesthesiologists task force on intraoperative awareness. Anesthesiology 2006; 104:847.</a></li><li><a class="nounderline abstract_t">Wakabayashi R. A Call for Real-Time Bispectral Index and Electroencephalogram Monitoring in a Patient Undergoing Aortic Surgery. J Cardiothorac Vasc Anesth 2022; 36:2558.</a></li><li><a class="nounderline abstract_t">Raghunathan K, Kerr D, Xian Y, et al. Cerebral Oximetry During Adult Cardiac Surgery Is Associated With Improved Postoperative Outcomes. J Cardiothorac Vasc Anesth 2022; 36:3529.</a></li><li><a class="nounderline abstract_t">Thiele RH, Shaw AD, Bartels K, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy. Anesth Analg 2020; 131:1444.</a></li><li><a class="nounderline abstract_t">Ali J, Cody J, Maldonado Y, Ramakrishna H. Near-Infrared Spectroscopy (NIRS) for Cerebral and Tissue Oximetry: Analysis of Evolving Applications. J Cardiothorac Vasc Anesth 2022; 36:2758.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112:1084.</a></li><li><a class="nounderline abstract_t">Cronin B, Kolotiniuk N, Youssefzadeh K, et al. Pulmonary Artery Catheter Placement Aided by Transesophageal Echocardiography versus Pressure Waveform Transduction. J Cardiothorac Vasc Anesth 2018; 32:2578.</a></li><li><a class="nounderline abstract_t">MacKay EJ, Zhang B, Augoustides JG, et al. Association of Intraoperative Transesophageal Echocardiography and Clinical Outcomes After Open Cardiac Valve or Proximal Aortic Surgery. JAMA Netw Open 2022; 5:e2147820.</a></li><li><a class="nounderline abstract_t">Yu S, Peffley S, Fabbro M 2nd, Mohammed AN. A Narrative Review of the 2020 Guidelines for Use of Transesophageal Echocardiography to Assist with Surgical Decision- Making by the Cardiac Anesthesiologist in the Operating Room. J Cardiothorac Vasc Anesth 2022; 36:258.</a></li><li><a class="nounderline abstract_t">MacKay EJ, Zhang B, Heng S, et al. Association between Transesophageal Echocardiography and Clinical Outcomes after Coronary Artery Bypass Graft Surgery. J Am Soc Echocardiogr 2021; 34:571.</a></li><li><a class="nounderline abstract_t">Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 2014; 118:21.</a></li><li><a class="nounderline abstract_t">Magoon R, Malik V, Choudhury A, et al. A Comparison of the Strain and Tissue Doppler-Based Indices as Echocardiographic Correlates of the Left Ventricular Filling Pressures. J Cardiothorac Vasc Anesth 2018; 32:1297.</a></li><li><a class="nounderline abstract_t">Zhang K, Sheu R, Zimmerman NM, et al. A Comparison of Global Longitudinal, Circumferential, and Radial Strain to Predict Outcomes After Cardiac Surgery. J Cardiothorac Vasc Anesth 2019; 33:1315.</a></li><li><a class="nounderline abstract_t">Hu J, Peng L, Qian H, et al. Transoesophageal echocardiography for prediction of postoperative atrial fibrillation after isolated aortic valve replacement: two-dimensional speckle tracking for intraoperative assessment of left ventricular longitudinal strain. Eur J Cardiothorac Surg 2015; 47:833.</a></li><li><a class="nounderline abstract_t">Swaminathan M, Nicoara A, Phillips-Bute BG, et al. Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. Ann Thorac Surg 2011; 91:1844.</a></li><li><a class="nounderline abstract_t">Bernard F, Denault A, Babin D, et al. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg 2001; 92:291.</a></li><li><a class="nounderline abstract_t">Metkus TS, Suarez-Pierre A, Crawford TC, et al. Diastolic dysfunction is common and predicts outcome after cardiac surgery. J Cardiothorac Surg 2018; 13:67.</a></li><li><a class="nounderline abstract_t">Beaubien-Souligny W, Brand FZA, Lenoir M, et al. Assessment of Left Ventricular Diastolic Function by Transesophageal Echocardiography Before Cardiopulmonary Bypass: Clinical Implications of a Restrictive Profile. J Cardiothorac Vasc Anesth 2019; 33:2394.</a></li><li><a class="nounderline abstract_t">Canty DJ, Kim M, Guha R, et al. Comparison of Cardiac Output of Both 2-Dimensional and 3-Dimensional Transesophageal Echocardiography With Transpulmonary Thermodilution During Cardiac Surgery. J Cardiothorac Vasc Anesth 2020; 34:77.</a></li><li><a class="nounderline abstract_t">Mark JB. Multimodal detection of perioperative myocardial ischemia. Tex Heart Inst J 2005; 32:461.</a></li><li><a class="nounderline abstract_t">Silverton NA, Lee JP, Morrissey CK, et al. Regional Versus Global Measurements of Right Ventricular Strain Performed in the Operating Room With Transesophageal Echocardiography. J Cardiothorac Vasc Anesth 2020; 34:48.</a></li><li><a class="nounderline abstract_t">Eltzschig HK, Rosenberger P, Löffler M, et al. Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg 2008; 85:845.</a></li><li><a class="nounderline abstract_t">Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 2015; 28:910.</a></li><li><a class="nounderline abstract_t">Krasuski RA, Hart SA, Allen D, et al. Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival. JAMA 2009; 302:290.</a></li><li><a class="nounderline abstract_t">Kirkpatrick JN, Mitchell C, Taub C, et al. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J Am Coll Cardiol 2020; 75:3078.</a></li><li><a class="nounderline abstract_t">Augoustides JG. Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic. J Cardiothorac Vasc Anesth 2020; 34:1416.</a></li><li><a class="nounderline abstract_t">Wood DA, Mahmud E, Thourani VH, et al. Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. J Am Coll Cardiol 2020; 75:3177.</a></li><li><a class="nounderline abstract_t">Markin NW, Cawcutt KA, Sayyed SH, et al. Transesophageal Echocardiography Probe Sheath to Decrease Provider and Environment Contamination. Anesthesiology 2020; 133:475.</a></li><li><a class="nounderline abstract_t">Nicoara A, Maldonado Y, Kort S, et al. Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2020; 33:666.</a></li><li><a class="nounderline abstract_t">Bovill JG, Sebel PS. Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery. Br J Anaesth 1980; 52:795.</a></li><li><a class="nounderline abstract_t">Komatsu R, Makarova N, You J, et al. Etomidate and the Risk of Complications After Cardiac Surgery: A Retrospective Cohort Analysis. J Cardiothorac Vasc Anesth 2016; 30:1516.</a></li><li><a class="nounderline abstract_t">Bennett JA, Abrams JT, Van Riper DF, Horrow JC. Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closure. Anesthesiology 1997; 87:1070.</a></li><li><a class="nounderline abstract_t">Jellish WS, Oftadeh M. Peripheral Nerve Injury in Cardiac Surgery. J Cardiothorac Vasc Anesth 2018; 32:495.</a></li><li><a class="nounderline abstract_t">Hickey C, Gugino LD, Aglio LS, et al. Intraoperative somatosensory evoked potential monitoring predicts peripheral nerve injury during cardiac surgery. Anesthesiology 1993; 78:29.</a></li><li><a class="nounderline abstract_t">Chong AY, Clarke CE, Dimitri WR, Lip GY. Brachial plexus injury as an unusual complication of coronary artery bypass graft surgery. Postgrad Med J 2003; 79:84.</a></li><li><a class="nounderline abstract_t">Bonanni A, Signori A, Alicino C, et al. Volatile Anesthetics versus Propofol for Cardiac Surgery with Cardiopulmonary Bypass: Meta-analysis of Randomized Trials. Anesthesiology 2020; 132:1429.</a></li><li><a class="nounderline abstract_t">Beverstock J, Park T, Alston RP, et al. A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) Effects on Outcome From Cardiac Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth 2021; 35:1096.</a></li><li><a class="nounderline abstract_t">Pagel PS, Crystal GJ. Contradictory Findings of Two Recent Meta-Analyses: What Are We Supposed to Believe About Anesthetic Technique in Patients Undergoing Cardiac Surgery? J Cardiothorac Vasc Anesth 2021; 35:3841.</a></li><li><a class="nounderline abstract_t">Peng K, Li D, Applegate RL 2nd, et al. Effect of Dexmedetomidine on Cardiac Surgery-Associated Acute Kidney Injury: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth 2020; 34:603.</a></li><li><a class="nounderline abstract_t">Jakobsen CJ, Berg H, Hindsholm KB, et al. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007; 21:664.</a></li><li><a class="nounderline abstract_t">Ansley DM, Raedschelders K, Choi PT, et al. Propofol cardioprotection for on-pump aortocoronary bypass surgery in patients with type 2 diabetes mellitus (PRO-TECT II): a phase 2 randomized-controlled trial. Can J Anaesth 2016; 63:442.</a></li><li><a class="nounderline abstract_t">Barry AE, Chaney MA, London MJ. Anesthetic management during cardiopulmonary bypass: a systematic review. Anesth Analg 2015; 120:749.</a></li><li><a class="nounderline abstract_t">Hudson RJ, Thomson IR, Jassal R, et al. Cardiopulmonary bypass has minimal effects on the pharmacokinetics of fentanyl in adults. Anesthesiology 2003; 99:847.</a></li><li><a class="nounderline abstract_t">Lagier D, Velly LJ, Guinard B, et al. Perioperative Open-lung Approach, Regional Ventilation, and Lung Injury in Cardiac Surgery. Anesthesiology 2020; 133:1029.</a></li><li><a class="nounderline abstract_t">Mathis MR, Duggal NM, Likosky DS, et al. Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications after Cardiac Surgery. Anesthesiology 2019; 131:1046.</a></li><li><a class="nounderline abstract_t">Jia Y, Leung SM, Turan A, et al. Low Tidal Volumes Are Associated With Slightly Improved Oxygenation in Patients Having Cardiac Surgery: A Cohort Analysis. Anesth Analg 2020; 130:1396.</a></li><li><a class="nounderline abstract_t">Chores JB, Holt DW. Colloid Oncotic Pressure, Monitoring its Effects in Cardiac Surgery. J Extra Corpor Technol 2017; 49:249.</a></li><li><a class="nounderline abstract_t">Mailhot T, Cossette S, Lambert J, et al. Delirium After Cardiac Surgery and Cumulative Fluid Balance: A Case-Control Cohort Study. J Cardiothorac Vasc Anesth 2019; 33:93.</a></li><li><a class="nounderline abstract_t">Lagny MG, Roediger L, Koch JN, et al. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study. J Cardiothorac Vasc Anesth 2016; 30:869.</a></li><li><a class="nounderline abstract_t">Reddy S, McGuinness S, Parke R, Young P. Choice of Fluid Therapy and Bleeding Risk After Cardiac Surgery. J Cardiothorac Vasc Anesth 2016; 30:1094.</a></li><li class="breakAll">US Food and Drug Administration: FDA Safety Communication: Boxed Warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm358271.htm. (Accessed on November 30, 2016).</li><li><a class="nounderline abstract_t">Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144:223.</a></li><li><a class="nounderline abstract_t">Futier E, Garot M, Godet T, et al. Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial. JAMA 2020; 323:225.</a></li><li><a class="nounderline abstract_t">Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; :CD007594.</a></li><li><a class="nounderline abstract_t">Kabon B, Sessler DI, Kurz A, Crystalloid–Colloid Study Team. Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity: A Randomized Trial. Anesthesiology 2019; 130:728.</a></li><li><a class="nounderline abstract_t">Kammerer T, Brettner F, Hilferink S, et al. No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial. Anesthesiology 2018; 128:67.</a></li><li><a class="nounderline abstract_t">Pagel JI, Rehm M, Kammerer T, et al. Hydroxyethyl Starch 130/0.4 and Its Impact on Perioperative Outcome: A Propensity Score Matched Controlled Observation Study. Anesth Analg 2018; 126:1949.</a></li><li><a class="nounderline abstract_t">Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116:35.</a></li><li><a class="nounderline abstract_t">Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014; 112:25.</a></li><li><a class="nounderline abstract_t">Lee MJ, Tannenbaum C, Mao G, et al. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial. Anesth Analg 2021; 133:906.</a></li><li><a class="nounderline abstract_t">Burchardi H, Kaczmarczyk G. The effect of anaesthesia on renal function. Eur J Anaesthesiol 1994; 11:163.</a></li><li><a class="nounderline abstract_t">Pierce B, Bole I, Patel V, Brown DL. Clinical Outcomes of Remote Ischemic Preconditioning Prior to Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">Long YQ, Feng XM, Shan XS, et al. Remote Ischemic Preconditioning Reduces Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg 2022; 134:592.</a></li><li><a class="nounderline abstract_t">Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91:944.</a></li><li><a class="nounderline abstract_t">Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:S27.</a></li><li><a class="nounderline abstract_t">Koch CG, Sessler DI, Mascha EJ, et al. A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg 2017; 104:1243.</a></li><li><a class="nounderline abstract_t">Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017; 377:2133.</a></li><li><a class="nounderline abstract_t">Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372:997.</a></li><li><a class="nounderline abstract_t">Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 2013; 41:1774.</a></li><li><a class="nounderline abstract_t">Owais K, Mahmood F, Khabbaz KR, Matyal R. Systolic Anterior Motion after Myocardial Revascularization-The Unusual Suspect. J Cardiothorac Vasc Anesth 2018; 32:1825.</a></li><li><a class="nounderline abstract_t">López-Sendón J, López de Sá E, González Maqueda I, et al. Right ventricular infarction as a risk factor for ventricular fibrillation during pulmonary artery catheterization using Swan-Ganz catheters. Am Heart J 1990; 119:207.</a></li><li><a class="nounderline abstract_t">Gaudino M, Nesta M, Burzotta F, et al. Results of emergency postoperative re-angiography after cardiac surgery procedures. Ann Thorac Surg 2015; 99:1576.</a></li><li><a class="nounderline abstract_t">Catchpole KR, de Leval MR, McEwan A, et al. Patient handover from surgery to intensive care: using Formula 1 pit-stop and aviation models to improve safety and quality. Paediatr Anaesth 2007; 17:470.</a></li><li><a class="nounderline abstract_t">Bonifacio AS, Segall N, Barbeito A, et al. Handovers from the OR to the ICU. Int Anesthesiol Clin 2013; 51:43.</a></li><li><a class="nounderline abstract_t">Dixon JL, Stagg HW, Wehbe-Janek H, et al. A standard handoff improves cardiac surgical patient transfer: operating room to intensive care unit. J Healthc Qual 2015; 37:22.</a></li><li><a class="nounderline abstract_t">Chatterjee S, Shake JG, Arora RC, et al. Handoffs From the Operating Room to the Intensive Care Unit After Cardiothoracic Surgery: From The Society of Thoracic Surgeons Workforce on Critical Care. Ann Thorac Surg 2019; 107:619.</a></li><li><a class="nounderline abstract_t">O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88:S23.</a></li><li><a class="nounderline abstract_t">Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2.</a></li><li><a class="nounderline abstract_t">Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001; 37:885.</a></li><li><a class="nounderline abstract_t">Gregory SH, Yalamuri SM, Bishawi M, Swaminathan M. The Perioperative Management of Ascending Aortic Dissection. Anesth Analg 2018; 127:1302.</a></li></ol></div><div id="topicVersionRevision">Topic 126473 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="www.asahq.org/Search.aspx?q=standards+basic+anesthetic+monitoring" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Society of Anesthesiologists. Standards for Basic Anesthetic Monitoring. www.asahq.org/Search.aspx?q=standards+basic+anesthetic+monitoring (Accessed on March 29, 2016).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26543248" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management during Cardiopulmonary Bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26234862" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24689001" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Temperature management in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17122206" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Temperature during cardiopulmonary bypass: the discrepancies between monitored sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17532957" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Reliability of temperatures measured at standard monitoring sites as an index of brain temperature during deep hypothermic cardiopulmonary bypass conducted for thoracic aortic reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881483" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Laboratory point-of-care monitoring in the operating room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23832623" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Safety and feasibility of transulnar catheterization when ipsilateral radial access is not available.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15950592" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Effectiveness of ulnar artery catheterization after failed attempt to cannulate a radial artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26716587" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ulnar Artery Interventions Non-Inferior to Radial Approach: AJmer Ulnar ARtery (AJULAR) Intervention Working Group Study Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15687529" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2360738" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Comparison of brachial and radial arterial pressure monitoring in patients undergoing coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28398932" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Brachial Arterial Pressure Monitoring during Cardiac Surgery Rarely Causes Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31821240" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Practice Guidelines for Central Venous Access 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26888253" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Association of Anaesthetists of Great Britain and Ireland: Safe vascular access 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064599" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26089166" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Clinical practice in perioperative monitoring in adult cardiac surgery: is there a standard of care? Results from an national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17096667" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26947712" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pulmonary Artery Catheter Use During Cardiac Surgery in the United States, 2010 to 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440650" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Current use of the pulmonary artery catheter in cardiac surgery: a survey study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16204662" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16084255" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12510037" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25689312" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Use of pulmonary artery catheter in coronary artery bypass graft. Costs and long-term outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25480764" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pulmonary artery catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24188220" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The pulmonary artery catheter: a critical reappraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27916322" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The Routine Use of the Pulmonary Artery Catheter Should Be Abandoned.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22253267" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16571982" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Practice advisory for intraoperative awareness and brain function monitoring: a report by the american society of anesthesiologists task force on intraoperative awareness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34551884" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A Call for Real-Time Bispectral Index and Electroencephalogram Monitoring in a Patient Undergoing Aortic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35691854" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cerebral Oximetry During Adult Cardiac Surgery Is Associated With Improved Postoperative Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33079868" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34362641" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Near-Infrared Spectroscopy (NIRS) for Cerebral and Tissue Oximetry: Analysis of Evolving Applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20418689" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29929894" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pulmonary Artery Catheter Placement Aided by Transesophageal Echocardiography versus Pressure Waveform Transduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35138396" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Association of Intraoperative Transesophageal Echocardiography and Clinical Outcomes After Open Cardiac Valve or Proximal Aortic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33744115" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A Narrative Review of the 2020 Guidelines for Use of Transesophageal Echocardiography to Assist with Surgical Decision- Making by the Cardiac Anesthesiologist in the Operating Room.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33508414" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Association between Transesophageal Echocardiography and Clinical Outcomes after Coronary Artery Bypass Graft Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356157" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29290381" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A Comparison of the Strain and Tissue Doppler-Based Indices as Echocardiographic Correlates of the Left Ventricular Filling Pressures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30581109" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A Comparison of Global Longitudinal, Circumferential, and Radial Strain to Predict Outcomes After Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24920107" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Transoesophageal echocardiography for prediction of postoperative atrial fibrillation after isolated aortic valve replacement: two-dimensional speckle tracking for intraoperative assessment of left ventricular longitudinal strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21492828" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11159219" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29903030" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Diastolic dysfunction is common and predicts outcome after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31235379" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Assessment of Left Ventricular Diastolic Function by Transesophageal Echocardiography Before Cardiopulmonary Bypass: Clinical Implications of a Restrictive Profile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31375406" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of Cardiac Output of Both 2-Dimensional and 3-Dimensional Transesophageal Echocardiography With Transpulmonary Thermodilution During Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16429887" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Multimodal detection of perioperative myocardial ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31401208" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Regional Versus Global Measurements of Right Ventricular Strain Performed in the Operating Room With Transesophageal Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18291154" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26239900" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19602688" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32272153" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32249075" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32380033" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32358249" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Transesophageal Echocardiography Probe Sheath to Decrease Provider and Environment Contamination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32503703" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7426257" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27554237" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Etomidate and the Risk of Complications After Cardiac Surgery: A Retrospective Cohort Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9366458" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29248326" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Peripheral Nerve Injury in Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8424568" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Intraoperative somatosensory evoked potential monitoring predicts peripheral nerve injury during cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12612322" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Brachial plexus injury as an unusual complication of coronary artery bypass graft surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32205551" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Volatile Anesthetics versus Propofol for Cardiac Surgery with Cardiopulmonary Bypass: Meta-analysis of Randomized Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33191042" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) Effects on Outcome From Cardiac Surgery: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34030958" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Contradictory Findings of Two Recent Meta-Analyses: What Are We Supposed to Believe About Anesthetic Technique in Patients Undergoing Cardiac Surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31587928" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of Dexmedetomidine on Cardiac Surgery-Associated Acute Kidney Injury: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17905271" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26721648" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Propofol cardioprotection for on-pump aortocoronary bypass surgery in patients with type 2 diabetes mellitus (PRO-TECT II): a phase 2 randomized-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25790208" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Anesthetic management during cardiopulmonary bypass: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14508316" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Cardiopulmonary bypass has minimal effects on the pharmacokinetics of fentanyl in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32902561" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Perioperative Open-lung Approach, Regional Ventilation, and Lung Injury in Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31403976" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications after Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31904632" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Low Tidal Volumes Are Associated With Slightly Improved Oxygenation in Patients Having Cardiac Surgery: A Cohort Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29302115" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Colloid Oncotic Pressure, Monitoring its Effects in Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30122614" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Delirium After Cardiac Surgery and Cumulative Fluid Balance: A Case-Control Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26774199" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161183" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Choice of Fluid Therapy and Bleeding Risk After Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161183" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Choice of Fluid Therapy and Bleeding Risk After Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22578894" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31961418" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20091640" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30882476" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity: A Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29064872" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29324500" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Hydroxyethyl Starch 130/0.4 and Its Impact on Perioperative Outcome: A Propensity Score Matched Controlled Observation Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23115254" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Safety of modern starches used during surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24046292" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34406128" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8050420" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The effect of anaesthesia on renal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28219918" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Clinical Outcomes of Remote Ischemic Preconditioning Prior to Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34748518" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Remote Ischemic Preconditioning Reduces Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21353044" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17462454" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28821336" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29130845" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Restrictive or liberal red-cell transfusion for cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25760354" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Liberal or restrictive transfusion after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23774337" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27842948" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Systolic Anterior Motion after Myocardial Revascularization-The Unusual Suspect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2296867" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Right ventricular infarction as a risk factor for ventricular fibrillation during pulmonary artery catheterization using Swan-Ganz catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25791925" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Results of emergency postoperative re-angiography after cardiac surgery procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17474955" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Patient handover from surgery to intensive care: using Formula 1 pit-stop and aviation models to improve safety and quality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23282721" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Handovers from the OR to the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26042374" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : A standard handoff improves cardiac surgical patient transfer: operating room to intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30500341" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Handoffs From the Operating Room to the Intensive Care Unit After Cardiothoracic Surgery: From The Society of Thoracic Surgeons Workforce on Critical Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559823" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559822" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11693766" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Prediction of operative mortality after valve replacement surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30211773" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : The Perioperative Management of Ascending Aortic Dissection.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
